Jasper Therapeutics (JSPR) Shares Outstanding (Entity) (2019 - 2026)
Jasper Therapeutics (JSPR) recorded Shares Outstanding (Entity) of 28.08 million in Q2 2026, up 73.1% from 16.22 million a year earlier.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
For FY2025, Jasper Therapeutics reported Shares Outstanding (Entity) of 19.17 million, up 27.6% from FY2024.
- Annual Shares Outstanding (Entity) has increased for six straight years, with a five-year compound annual growth rate of 70.6% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Entity) came in at 15.02 million in FY2024 (+34.6%), 11.16 million in FY2023 (+193.4%), 3.8 million in FY2022 (+69.1%) and 2.25 million in FY2021 (+69.8%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2019.
- On a year-over-year basis, Shares Outstanding (Entity) rose in six of the last seven quarters, with growth averaging 26.9%.
- Peak year-over-year performance for Shares Outstanding (Entity) in the last five years was growth of 193.4% in Q4 2023, against a decline of 0.4% in Q1 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 941.36 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 2.41 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 540.60 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Jasper Therapeutics | 14.47 Mn | -111.94 Mn | - | 28.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.08 Mn |
| Dec 31, 2025 | 19.17 Mn |
| Sep 30, 2025 | 16.64 Mn |
| Jun 30, 2025 | 16.22 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 15.02 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 15.11 Mn |
| Mar 31, 2024 | 15.09 Mn |
| Dec 31, 2023 | 11.16 Mn |
| Sep 30, 2023 | 11.09 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 8.82 Mn |
| Dec 31, 2022 | 3.80 Mn |
| Sep 30, 2022 | 3.80 Mn |
| Jun 30, 2022 | 3.80 Mn |
| Mar 31, 2022 | 3.79 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
API Access
Jasper Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=JSPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "JSPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=JSPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();